BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 31

• Business

  Mylan Names Kenneth Parks Chief Financial Officer

  May 3, 2016

   · 

  3 min read
• Drug Development

  Envisia Therapeutics Announces Positive Three-Month Interim Results Of Low Dose ENV515 In Patients With Glaucoma

  May 3, 2016

   · 

  3 min read
• Genetown

  Hologic Release: New Study Further Supports Screening With Pap+HPV Together As Best Way To Detect Cervical Cancer And Pre-Cancer

  May 3, 2016

   · 

  5 min read
• Drug Development

  Tocagen Inc. Presents Intravenous Toca 511 Clinical Data At The 84th AANS Annual Scientific Meeting

  May 3, 2016

   · 

  2 min read
• Biotech Bay

  Data from Multiple Studies Evaluating Veracyte’s Genomic Classifiers For Lung Cancer And Idiopathic Pulmonary Fibrosis To Be Presented At American Thoracic Society 2016

  May 3, 2016

   · 

  7 min read
• BioMidwest

  Monteris Medical, Inc. Release: New Data Supporting Clinical Utility Of Laser Interstitial Thermal Therapy (LITT) For Brain Lesions Presented At AANS 2016

  May 3, 2016

   · 

  3 min read
• Business

  Eiger Biopharma Strengthens Senior Management Team With Announcement Of Debra Odink, PhD As Senior Vice President Of Technical Operations

  May 3, 2016

   · 

  3 min read
• Business

  Jiangsu Hengrui Medicine Co. Ltd. Enters Into Agreement With The University of Texas MD Anderson Cancer Center To Advance Immunotherapy And Precision Medicine For Cancer Treatment

  May 3, 2016

   · 

  1 min read
• Policy

  ImmunID Receives CLIA Certification From The US Centers For Medicare & Medicaid Services

  May 3, 2016

   · 

  3 min read
• Business

  Mount Sinai And Galmed Pharmaceuticals To Collaborate In An Investigator Initiated Phase Ila Trial To Evaluate The Effect Of AramcholTM In Combination With Vitamin D For The Treatment Of Patients With Fibrotic Nonalcoholic Fatty Liver Disease

  May 3, 2016

   · 

  7 min read